Skip to main content

#154014

Anti-Human Insulin receptor (IR) [18-40]

Cat. #154014

Anti-Human Insulin receptor (IR) [18-40]

Cat. #: 154014

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Human Insulin receptor

Class: Monoclonal

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: University of Cambridge

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Human Insulin receptor (IR) [18-40]
  • Alternate name: IR, hIR, INSR
  • Research fields: Cell signaling and signal transduction;Metabolism
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 135 kDa
  • Reactivity: Human
  • Host: Mouse
  • Description: Human Insulin Receptor (IR) is a transmembrane tyrosine kinase receptor for insulin. It plays a role in glucose homeostasis by controlling the glucose transport to cells. Malfunction of IR include clinical manifestations such as cancer and diabetes.
  • Immunogen: Affinity-purified human insulin receptor
  • Isotype: IgG1
  • Myeloma used: NS0

Target Details

  • Target: Human Insulin receptor
  • Molecular weight: 135 kDa
  • Target background: Human Insulin Receptor (IR) is a transmembrane tyrosine kinase receptor for insulin. It plays a role in glucose homeostasis by controlling the glucose transport to cells. Malfunction of IR include clinical manifestations such as cancer and diabetes.

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Soos et al. 1986. Biochem J. 235(1):199-208. PMID: 2427071.
  • Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.